Ginkgo Bioworks Holdings, Inc. (DNA)

USD 7.71

(-4.76%)

Revenue Summary of Ginkgo Bioworks Holdings, Inc.

  • Ginkgo Bioworks Holdings, Inc.'s latest annual revenue in 2023 was 251.45 Million USD , down -47.36% from previous year.
  • Ginkgo Bioworks Holdings, Inc.'s latest quarterly revenue in 2024 Q1 was 37.94 Million USD , up 9.18% from previous quarter.
  • Ginkgo Bioworks Holdings, Inc. reported a annual revenue of 477.7 Million USD in annual revenue 2022, up 52.21% from previous year.
  • Ginkgo Bioworks Holdings, Inc. reported a annual revenue of 313.83 Million USD in annual revenue 2021, up 309.4% from previous year.
  • Ginkgo Bioworks Holdings, Inc. reported a quarterly revenue of 56.2 Million USD for 2024 Q2, up 48.13% from previous quarter.
  • Ginkgo Bioworks Holdings, Inc. reported a quarterly revenue of 55.43 Million USD for 2023 Q3, down -31.2% from previous quarter.

Annual Revenue Chart of Ginkgo Bioworks Holdings, Inc. (2023 - 2001)

Historical Annual Revenue of Ginkgo Bioworks Holdings, Inc. (2023 - 2001)

Year Revenue Revenue Growth
2023 251.45 Million USD -47.36%
2022 477.7 Million USD 52.21%
2021 313.83 Million USD 309.4%
2020 76.65 Million USD 41.48%
2019 54.18 Million USD 0.0%
2001 98.28 Million USD 0.0%

Peer Revenue Comparison of Ginkgo Bioworks Holdings, Inc.

Name Revenue Revenue Difference
ADC Therapeutics SA 69.55 Million USD -261.504%
Alto Neuroscience, Inc. - USD -Infinity%
Annovis Bio, Inc. - USD -Infinity%
Biohaven Pharmaceutical Holding Company Ltd. - USD -Infinity%
Nuvation Bio Inc. - USD -Infinity%
Nuvation Bio Inc. - USD -Infinity%
Arcus Biosciences, Inc. 117 Million USD -114.919%
Zymeworks Inc. 76.01 Million USD -230.81%